The American peptide market is undergoing a rapid transformation, with Bitcoin becoming a key driver of this process. According to blockchain analytics, in the first quarter of 2026, sellers of such drugs received $32 million in cryptocurrency from US buyers. This represents a massive 700% increase compared to the same period last year.
Peptides, which are marketed as aids for weight loss, muscle gain, and even life extension, are rapidly gaining popularity. Legal, approved drugs are sold through pharmacy chains like Walgreens, but a significant portion of online trade operates in a gray zone. Cheap analogs are shipped directly from foreign laboratories, bypassing prescriptions and insurance, and some packages even bear the label "not for human use."
Why Bitcoin Became the Currency of Choice
The reason for the shift to cryptocurrency is obvious: traditional banks and payment systems refuse to serve such sellers due to high compliance risks. Therefore, many suppliers accept payment exclusively in Bitcoin. Notably, for some buyers, this becomes their first experience with digital assets. For example, 49-year-old marketer Zach from the US, who was looking for the drug retatrutide, found a Chinese supplier willing to ship 20 vials for $240 — compared to $300 per month on the American market. The only condition was payment in Bitcoin, forcing Zach to purchase cryptocurrency for the first time in his life.
Stages of Growth: From the Underground to TikTok
Analysts identify three key stages in the evolution of this market. Before 2025, it was a niche "underground" with a monthly inflow of about $200,000. Then the topic came into the spotlight of the Make America Healthy Again movement, coinciding with the appointment of Robert F. Kennedy Jr. as head of the US Department of Health and Human Services. However, the real explosion occurred in late 2025, when peptides went viral in the TikTok subculture of looksmaxxing. The monthly inflow grew roughly fourfold — to $9.9 million, and in peak months exceeded $10 million.
For comparison, according to estimates from a former Coinbase employee, the annual turnover of the peptide market in 2023 was about $100 million. Data from TRM Labs for 2025 shows inflows of $41.4 million — a 20% increase year-over-year. The global director of policy for this platform compares the current dynamics to the early stages of shadow online markets like Silk Road.
Major Players Prefer Stablecoins
The market is unevenly structured. The bulk of transactions come from a narrow group of large sellers. Small players experiment with different coins, but large suppliers almost exclusively use Bitcoin and stablecoins. Sellers with an average deposit of $1,000 or more are increasingly switching to "stable coins" to hedge against exchange rate volatility in large and cross-border purchases.
The Chinese Connection
The primary raw materials for peptides are produced in China. Over the three quarters of last year, imports from China to the US roughly doubled — to over $300 million. Some suppliers entered this sector from the drug trade. For example, Chinese company Bigreat Technology, which previously supplied fentanyl precursors to markets in Russia and Kazakhstan, created a separate legal entity for trading cosmetic peptides.
Expert Opinion: The peptide market demonstrates a classic pattern of shadow economy evolution: first niche interest, then explosive growth driven by social media, and finally institutionalization through cryptocurrencies. The current dynamics are a vivid example of how blockchain is becoming not just a speculative tool but a real payment method for markets bypassing traditional financial systems. However, regulators should take note of this trend: if volumes continue to grow, we may see stricter measures from authorities.